30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Insight Molecular Diagnostics Inc (IMDX)

Track

Over the last 90 days, Insight Molecular Diagnostics Inc. has seen a net buy of $2.69 million from one insider. All six transactions were purchases, totaling $2.69 million. The company's stock has increased by 19.6% in the past 90 days. The last earnings report showed a 54.29% beat.
Stock chart
Ticker: IMDX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
BROADWOOD PARTNERS, L.P.
1 purchase — total 913,134 USD
Buy 27 Apr 2026
Value US$2,753,985.44 | Price 85.80 | Shares 41,979
Buy 24 Apr 2026
Value US$491,660.79 | Price 275.57 | Shares 6,261
Buy 23 Apr 2026
Value US$982,034.45 | Price 3.50 | Shares 280,381
Buy 20 Apr 2026
Value US$157,966.72 | Price 3.88 | Shares 40,690
Buy 17 Apr 2026
Value US$143,251.11 | Price 3.57 | Shares 40,114
Buy 16 Apr 2026
Value US$351,657.80 | Price 3.45 | Shares 102,057
Buy 10 Feb 2026
Value US$2,999,999.25 | Price 5.75 | Shares 521,739
Buy 7 Feb 2025
Value US$200,000.05 | Price 2.05 | Shares 97,561
Buy 7 Feb 2025
Value US$2,209,080.00 | Price 2.05 | Shares 1,077,600
Buy 6 Feb 2025
Value US$9,236,250.40 | Price 2.05 | Shares 4,505,488
Buy 6 Feb 2025
Value US$1,353,424.35 | Price 2.05 | Shares 660,207
Buy 4 Feb 2025
Value US$50.50 | Price 2.02 | Shares 25
Buy 31 Jan 2025
Value US$1,788.90 | Price 2.01 | Shares 890
Buy 30 Jan 2025
Value US$639.18 | Price 2.01 | Shares 318
Buy 29 Jan 2025
Value US$7,798.80 | Price 2.01 | Shares 3,880
Buy 14 Jan 2025
Value US$22,114.90 | Price 2.15 | Shares 10,286
Buy 14 Jan 2025
Value US$208.00 | Price 2.08 | Shares 100
Buy 13 Jan 2025
Value US$11,791.52 | Price 2.08 | Shares 5,669
Buy 26 Dec 2024
Value US$192,166.47 | Price 2.13 | Shares 90,219
Buy 26 Dec 2024
Value US$26,350.00 | Price 2.11 | Shares 12,500
Buy 5 Dec 2024
Value US$45,800.00 | Price 2.29 | Shares 20,000
Buy 2 Oct 2024
Value US$99,999.90 | Price 2.97 | Shares 33,670
Buy 2 Oct 2024
Value US$3,877,619.37 | Price 2.95 | Shares 1,315,339
Buy 11 Apr 2024
Value US$99,999.10 | Price 2.95 | Shares 33,898
Buy 11 Apr 2024
Value US$7,057,688.00 | Price 2.92 | Shares 2,420,000
Buy 11 Apr 2024
Value US$10,000.50 | Price 2.95 | Shares 3,390
Buy 14 Jun 2023
Value US$6,447.00 | Price 0.21 | Shares 30,000
Buy 5 Apr 2023
Value US$200,027.10 | Price 0.30 | Shares 663,000
Buy 3 Apr 2023
Value US$0.00 | Price 0.00 | Shares 0
Buy 3 Apr 2023
Value US$8,093,898.38 | Price 0.30 | Shares 26,827,638
Buy 23 Dec 2022
Value US$24,727.50 | Price 0.33 | Shares 75,000
Buy 23 Dec 2022
Value US$87,875.00 | Price 0.35 | Shares 250,000
Buy 22 Dec 2022
Value US$7,125.00 | Price 0.29 | Shares 25,000
Buy 17 Aug 2022
Value US$6,750.00 | Price 0.90 | Shares 7,500
Buy 17 Aug 2022
Value US$6,750.00 | Price 0.90 | Shares 7,500
Buy 17 Aug 2022
Value US$17,400.00 | Price 0.87 | Shares 20,000
Buy 16 Aug 2022
Value US$38,400.00 | Price 0.96 | Shares 40,000
Buy 16 Aug 2022
Value US$112,057.31 | Price 0.97 | Shares 115,523
Buy 16 Aug 2022
Value US$10,000.00 | Price 1.00 | Shares 10,000
Buy 16 Aug 2022
Value US$9,975.00 | Price 0.95 | Shares 10,500
Buy 15 Aug 2022
Value US$23,250.00 | Price 0.93 | Shares 25,000
Buy 15 Aug 2022
Value US$32,063.61 | Price 0.93 | Shares 34,477
Buy 15 Aug 2022
Value US$4,850.00 | Price 0.97 | Shares 5,000
Buy 15 Aug 2022
Value US$4,850.00 | Price 0.97 | Shares 5,000
Sale 24 Jun 2022
Value US$41,552.48 | Price 1.03 | Shares 40,464
Sale 24 Jun 2022
Value US$13,160.37 | Price 1.05 | Shares 12,517
Sale 24 Jun 2022
Value US$36,394.36 | Price 1.03 | Shares 35,441
Sale 24 Jun 2022
Value US$11,527.55 | Price 1.05 | Shares 10,964
Sale 18 May 2022
Value US$9,265.92 | Price 1.14 | Shares 8,128
Buy 14 Apr 2022
Value US$1,840,766.14 | Price 1.33 | Shares 1,381,438
Buy 14 Apr 2022
Value US$1,023,296.04 | Price 1.33 | Shares 767,952
Buy 14 Apr 2022
Value US$72,613.80 | Price 1.26 | Shares 57,630
Buy 14 Apr 2022
Value US$23,570.67 | Price 1.23 | Shares 19,210
Buy 14 Apr 2022
Value US$2,553,628.32 | Price 1.33 | Shares 1,916,419
Buy 14 Apr 2022
Value US$116,386.20 | Price 1.26 | Shares 92,370
Buy 14 Apr 2022
Value US$37,779.33 | Price 1.23 | Shares 30,790
Buy 14 Apr 2022
Value US$2,219,809.08 | Price 1.33 | Shares 1,665,898
Buy 14 Apr 2022
Value US$0.00 | Price 0.00 | Shares 0
Buy 14 Apr 2022
Value US$7,999,999.54 | Price 1.33 | Shares 6,003,752
Buy 25 Mar 2022
Value US$21,000.00 | Price 1.40 | Shares 15,000
Buy 17 Mar 2022
Value US$19,767.00 | Price 1.20 | Shares 16,500
Buy 16 Mar 2022
Value US$64,150.00 | Price 1.28 | Shares 50,000
Buy 16 Mar 2022
Value US$47,560.00 | Price 1.19 | Shares 40,000
Buy 15 Mar 2022
Value US$29,150.00 | Price 1.17 | Shares 25,000
Buy 19 Mar 2021
Value US$52,702.10 | Price 4.79 | Shares 11,000
Buy 5 Feb 2021
Value US$0.00 | Price 0.00 | Shares 0
Buy 5 Feb 2021
Value US$2,700,000.00 | Price 4.50 | Shares 600,000
Buy 20 Jan 2021
Value US$0.00 | Price 0.00 | Shares 0
Buy 20 Jan 2021
Value US$4,999,998.72 | Price 3.42 | Shares 1,460,280
Sale 23 Dec 2020
Value US$2,295.00 | Price 2.55 | Shares 900
Sale 22 Dec 2020
Value US$0.00 | Price 0.00 | Shares 7,652
Sale 21 Dec 2020
Value US$13,075.92 | Price 2.54 | Shares 5,148
Sale 21 Dec 2020
Value US$0.00 | Price 0.00 | Shares 30,000
Buy 3 Aug 2020
Value US$6,533.00 | Price 1.31 | Shares 5,000
Buy 3 Aug 2020
Value US$6,648.00 | Price 1.33 | Shares 5,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-27 2026-04-27 B Purchase
3.5
BROADWOOD PARTNERS, L.P.
Large shareholder
41,979 +41.0%
85.80
US$2,753,985 		41,979 +41.0% 85.80 US$2,753,985
2026-04-27 2026-04-24 B Purchase
3.5
BROADWOOD PARTNERS, L.P.
Large shareholder
6,261 -9.4%
275.57
US$491,661 		6,261 -9.4% 275.57 US$491,661
2026-04-27 2026-04-23 B Purchase
3.5
BROADWOOD PARTNERS, L.P.
Large shareholder
93,880 -27.2%
118.25
US$2,015,470 		93,880 -27.2% 118.25 US$2,015,470
2026-04-20 2026-04-20 B Purchase
3.5
BROADWOOD PARTNERS, L.P.
Large shareholder
40,690 +0.3%
3.88
US$157,967 		40,690 +0.3% 3.88 US$157,967
2026-04-20 2026-04-17 B Purchase
3.5
BROADWOOD PARTNERS, L.P.
Large shareholder
40,114 +0.3%
3.57
US$143,251 		40,114 +0.3% 3.57 US$143,251
2026-04-20 2026-04-16 B Purchase
3.5
BROADWOOD PARTNERS, L.P.
Large shareholder
102,057 +0.9%
3.45
US$351,658 		102,057 +0.9% 3.45 US$351,658
2026-02-12 2026-02-10 B Purchase
3.5
BROADWOOD PARTNERS, L.P.
Large shareholder
521,739 +4.6%
5.75
US$2,999,999 		521,739 +4.6% 5.75 US$2,999,999
2025-02-11 2025-02-07 B Purchase
3.6
James Andrea S.

Chief Financial Officer

Officer
97,561 +181.8%
2.05
US$200,000 		97,561 +181.8% 2.05 US$200,000
2025-02-11 2025-02-07 B Purchase
4.0
SMITH PATRICK W
Large shareholder
1,077,600 +60.0%
2.05
US$2,209,080 		1,077,600 +60.0% 2.05 US$2,209,080
2025-02-10 2025-02-06 B Purchase
3.5
BROADWOOD PARTNERS, L.P.
Large shareholder
4,505,488 +65.3%
2.05
US$9,236,250 		4,505,488 +65.3% 2.05 US$9,236,250
2025-02-10 2025-02-06 B Purchase
3.5
BROADWOOD PARTNERS, L.P.
Large shareholder
660,207 +10.6%
2.05
US$1,353,424 		660,207 +10.6% 2.05 US$1,353,424
2025-02-04 2025-02-04 B Purchase
4.0
SMITH PATRICK W
Large shareholder
25 +0.0%
2.02
US$50 		25 +0.0% 2.02 US$50
2025-02-04 2025-01-31 B Purchase
4.0
SMITH PATRICK W
Large shareholder
890 +0.0%
2.01
US$1,789 		890 +0.0% 2.01 US$1,789
2025-01-31 2025-01-30 B Purchase
4.0
SMITH PATRICK W
Large shareholder
318 +0.0%
2.01
US$639 		318 +0.0% 2.01 US$639
2025-01-31 2025-01-29 B Purchase
4.0
SMITH PATRICK W
Large shareholder
3,880 +0.2%
2.01
US$7,799 		3,880 +0.2% 2.01 US$7,799
2025-01-15 2025-01-14 B Purchase
4.0
SMITH PATRICK W
Large shareholder
10,286 +0.6%
2.15
US$22,115 		10,286 +0.6% 2.15 US$22,115
2025-01-15 2025-01-14 B Purchase
4.0
SMITH PATRICK W
Large shareholder
100 +0.0%
2.08
US$208 		100 +0.0% 2.08 US$208
2025-01-15 2025-01-13 B Purchase
4.0
SMITH PATRICK W
Large shareholder
5,669 +0.3%
2.08
US$11,792 		5,669 +0.3% 2.08 US$11,792
2024-12-27 2024-12-26 B Purchase
4.0
SMITH PATRICK W
Large shareholder
90,219 +5.4%
2.13
US$192,166 		90,219 +5.4% 2.13 US$192,166
2024-12-26 2024-12-26 B Purchase
2.5
Arno Andrew
Non-Executive Director
12,500 +18.1%
2.11
US$26,350 		12,500 +18.1% 2.11 US$26,350
2024-12-09 2024-12-05 B Purchase
3.6
James Andrea S.

Chief Financial Officer

Officer
20,000 +59.4%
2.29
US$45,800 		20,000 +59.4% 2.29 US$45,800
2024-10-04 2024-10-02 B Purchase
3.6
James Andrea S.

Chief Financial Officer

Officer
33,670 +inf%
2.97
US$100,000 		33,670 +inf% 2.97 US$100,000
2024-10-04 2024-10-02 B Purchase
3.5
BROADWOOD PARTNERS, L.P.
Large shareholder
1,315,339 +26.7%
2.95
US$3,877,619 		1,315,339 +26.7% 2.95 US$3,877,619
2024-04-15 2024-04-11 B Purchase
2.5
Arno Andrew
Non-Executive Director
33,898 +96.4%
2.95
US$99,999 		33,898 +96.4% 2.95 US$99,999
2024-04-15 2024-04-11 B Purchase
3.5
BROADWOOD PARTNERS, L.P.
Large shareholder
2,420,000 +96.5%
2.92
US$7,057,688 		2,420,000 +96.5% 2.92 US$7,057,688
2024-04-15 2024-04-11 B Purchase
2.1
Riggs Josh

CEO and President

Executive Director
3,390 +2947.8%
2.95
US$10,000 		3,390 +2947.8% 2.95 US$10,000
2023-06-15 2023-06-14 B Purchase
1.7
KINGSLEY ALFRED D
Non-Executive Director
30,000 +6.8%
0.21
US$6,447 		30,000 +6.8% 0.21 US$6,447
2023-04-07 2023-04-05 B Purchase
1.8
PURA VIDA INVESTMENTS, LLC
Large shareholder
663,000 +8.9%
0.30
US$200,027 		663,000 +8.9% 0.30 US$200,027
2023-04-05 2023-04-03 B Purchase
3.5
BROADWOOD PARTNERS, L.P.
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2023-04-05 2023-04-03 B Purchase
3.5
BROADWOOD PARTNERS, L.P.
Large shareholder
26,827,638 +114.9%
0.30
US$8,093,898 		26,827,638 +114.9% 0.30 US$8,093,898
2022-12-28 2022-12-23 B Purchase
1.7
Gutfreund John Peter
Non-Executive Director
75,000 +inf%
0.33
US$24,728 		75,000 +inf% 0.33 US$24,728
2022-12-28 2022-12-23 B Purchase
2.5
Arno Andrew
Non-Executive Director
250,000 +88.6%
0.35
US$87,875 		250,000 +88.6% 0.35 US$87,875
2022-12-27 2022-12-22 B Purchase
1.7
KINGSLEY ALFRED D
Non-Executive Director
25,000 +6.0%
0.29
US$7,125 		25,000 +6.0% 0.29 US$7,125
2022-08-19 2022-08-17 B Purchase
2.5
Arno Andrew
Non-Executive Director
7,500 +100.0%
0.90
US$6,750 		7,500 +100.0% 0.90 US$6,750
2022-08-19 2022-08-17 B Purchase
2.5
Arno Andrew
Non-Executive Director
7,500 +100.0%
0.90
US$6,750 		7,500 +100.0% 0.90 US$6,750
2022-08-19 2022-08-17 B Purchase
2.1
Last Andrew J.
Non-Executive Director
20,000 +39.9%
0.87
US$17,400 		20,000 +39.9% 0.87 US$17,400
2022-08-18 2022-08-16 B Purchase
2.6
ANDREWS RONALD ASBURY

President & CEO

Executive Director
40,000 +13.6%
0.96
US$38,400 		40,000 +13.6% 0.96 US$38,400
2022-08-17 2022-08-16 B Purchase
2.5
Arno Andrew
Non-Executive Director
115,523 +69.4%
0.97
US$112,057 		115,523 +69.4% 0.97 US$112,057
2022-08-17 2022-08-16 B Purchase
0.5
GRIFFITH MELINDA
Non-Executive Director
10,000 +50.0%
1.00
US$10,000 		10,000 +50.0% 1.00 US$10,000
2022-08-17 2022-08-16 B Purchase
0.6
Carter Jennifer L.
Non-Executive Director
10,500 +52.5%
0.95
US$9,975 		10,500 +52.5% 0.95 US$9,975
2022-08-17 2022-08-15 B Purchase
1.7
Gutfreund John Peter
Non-Executive Director
25,000 +inf%
0.93
US$23,250 		25,000 +inf% 0.93 US$23,250
2022-08-17 2022-08-15 B Purchase
2.5
Arno Andrew
Non-Executive Director
34,477 +26.1%
0.93
US$32,064 		34,477 +26.1% 0.93 US$32,064
2022-08-17 2022-08-15 B Purchase
1.7
KINGSLEY ALFRED D
Non-Executive Director
5,000 +1.2%
0.97
US$4,850 		5,000 +1.2% 0.97 US$4,850
2022-08-17 2022-08-15 B Purchase
1.7
KINGSLEY ALFRED D
Non-Executive Director
5,000 +1.2%
0.97
US$4,850 		5,000 +1.2% 0.97 US$4,850
2022-06-28 2022-06-24 S Sale
1.8
PURA VIDA INVESTMENTS, LLC
Large shareholder
40,464 -0.5%
1.03
US$41,552 		40,464 -0.5% 1.03 US$41,552
2022-06-28 2022-06-24 S Sale
1.8
PURA VIDA INVESTMENTS, LLC
Large shareholder
12,517 -0.1%
1.05
US$13,160 		12,517 -0.1% 1.05 US$13,160
2022-06-28 2022-06-24 S Sale
1.8
PURA VIDA INVESTMENTS, LLC
Large shareholder
35,441 -0.5%
1.03
US$36,394 		35,441 -0.5% 1.03 US$36,394
2022-06-28 2022-06-24 S Sale
1.8
PURA VIDA INVESTMENTS, LLC
Large shareholder
10,964 -0.1%
1.05
US$11,528 		10,964 -0.1% 1.05 US$11,528
2022-05-19 2022-05-18 S Sale
3.1
Yu Li

VP Cntrllr/Prncpl Acctng Offcr

Officer
8,128 -32.5%
1.14
US$9,266 		8,128 -32.5% 1.14 US$9,266
2022-04-18 2022-04-14 B Purchase
1.8
PURA VIDA INVESTMENTS, LLC
Large shareholder
1,381,438 +inf%
1.33
US$1,840,766 		1,381,438 +inf% 1.33 US$1,840,766
2022-04-18 2022-04-14 B Purchase
1.8
PURA VIDA INVESTMENTS, LLC
Large shareholder
767,952 +inf%
1.33
US$1,023,296 		767,952 +inf% 1.33 US$1,023,296
2022-04-18 2022-04-14 B Purchase
1.8
PURA VIDA INVESTMENTS, LLC
Large shareholder
57,630 +0.7%
1.26
US$72,614 		57,630 +0.7% 1.26 US$72,614
2022-04-18 2022-04-14 B Purchase
1.8
PURA VIDA INVESTMENTS, LLC
Large shareholder
19,210 +0.2%
1.23
US$23,571 		19,210 +0.2% 1.23 US$23,571
2022-04-18 2022-04-14 B Purchase
1.8
PURA VIDA INVESTMENTS, LLC
Large shareholder
1,916,419 +29.3%
1.33
US$2,553,628 		1,916,419 +29.3% 1.33 US$2,553,628
2022-04-18 2022-04-14 B Purchase
1.8
PURA VIDA INVESTMENTS, LLC
Large shareholder
92,370 +1.3%
1.26
US$116,386 		92,370 +1.3% 1.26 US$116,386
2022-04-18 2022-04-14 B Purchase
1.8
PURA VIDA INVESTMENTS, LLC
Large shareholder
30,790 +0.4%
1.23
US$37,779 		30,790 +0.4% 1.23 US$37,779
2022-04-18 2022-04-14 B Purchase
1.8
PURA VIDA INVESTMENTS, LLC
Large shareholder
1,665,898 +29.3%
1.33
US$2,219,809 		1,665,898 +29.3% 1.33 US$2,219,809
2022-04-15 2022-04-14 B Purchase
3.5
BROADWOOD PARTNERS, L.P.
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2022-04-15 2022-04-14 B Purchase
3.5
BROADWOOD PARTNERS, L.P.
Large shareholder
6,003,752 +34.6%
1.33
US$8,000,000 		6,003,752 +34.6% 1.33 US$8,000,000
2022-03-28 2022-03-25 B Purchase
0.6
Ross Douglas T.

Chief Scientific Officer

Officer
15,000 +282.1%
1.40
US$21,000 		15,000 +282.1% 1.40 US$21,000
2022-03-17 2022-03-17 B Purchase
1.3
Paulsen Gisela

Chief Operating Officer

Officer
16,500 +inf%
1.20
US$19,767 		16,500 +inf% 1.20 US$19,767
2022-03-17 2022-03-16 B Purchase
2.6
ANDREWS RONALD ASBURY

Chief Executive Officer

Executive Director
50,000 +20.6%
1.28
US$64,150 		50,000 +20.6% 1.28 US$64,150
2022-03-16 2022-03-16 B Purchase
1.3
Redmond Cavan M.
Non-Executive Director
40,000 +56.4%
1.19
US$47,560 		40,000 +56.4% 1.19 US$47,560
2022-03-15 2022-03-15 B Purchase
2.6
Levine Mitchell S

Chief Financial Officer

Officer
25,000 +40.3%
1.17
US$29,150 		25,000 +40.3% 1.17 US$29,150
2021-03-22 2021-03-19 B Purchase
2.6
ANDREWS RONALD ASBURY

Chief Executive Officer

Executive Director
11,000 +10.7%
4.79
US$52,702 		11,000 +10.7% 4.79 US$52,702
2021-02-09 2021-02-05 B Purchase
3.5
BROADWOOD PARTNERS, L.P.
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2021-02-09 2021-02-05 B Purchase
3.5
BROADWOOD PARTNERS, L.P.
Large shareholder
600,000 +3.7%
4.50
US$2,700,000 		600,000 +3.7% 4.50 US$2,700,000
2021-01-22 2021-01-20 B Purchase
3.5
BROADWOOD PARTNERS, L.P.
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2021-01-22 2021-01-20 B Purchase
3.5
BROADWOOD PARTNERS, L.P.
Large shareholder
1,460,280 +9.9%
3.42
US$4,999,999 		1,460,280 +9.9% 3.42 US$4,999,999
2020-12-28 2020-12-23 S Sale
1.7
KINGSLEY ALFRED D
Non-Executive Director
900 -0.3%
2.55
US$2,295 		900 -0.3% 2.55 US$2,295
2020-12-23 2020-12-22 S Sale
1.7
KINGSLEY ALFRED D
Non-Executive Director
7,652
0.00
US$0 		7,652 0.00 US$0
2020-12-23 2020-12-21 S Sale
1.7
KINGSLEY ALFRED D
Non-Executive Director
5,148 -1.6%
2.54
US$13,076 		5,148 -1.6% 2.54 US$13,076
2020-12-23 2020-12-21 S Sale
1.7
KINGSLEY ALFRED D
Non-Executive Director
30,000
0.00
US$0 		30,000 0.00 US$0
2020-08-05 2020-08-03 B Purchase
2.7
KALAJIAN TONY T

Sr.VP/Chief Accounting Officer

Officer
5,000 +50.0%
1.31
US$6,533 		5,000 +50.0% 1.31 US$6,533
2020-08-05 2020-08-03 B Purchase
2.3
Parker Albert P

Chief Operating Officer

Officer
5,000 +inf%
1.33
US$6,648 		5,000 +inf% 1.33 US$6,648
Explore more

More insider trading research around Insight Molecular Diagnostics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America